(Q44466837)

English

The non-steroidal anti-inflammatory drug diclofenac sodium attenuates IFN-alpha induced alterations to monoamine turnover in prefrontal cortex and hippocampus

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

The non-steroidal anti-inflammatory drug diclofenac sodium attenuates IFN-alpha induced alterations to monoamine turnover in prefrontal cortex and hippocampus (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Richard De La Garza

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Gregory M Asnis

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

language of work or name

0 references

publication date

1 July 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

977

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

70-79

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Effects of chronic administration of interferon alpha A/D on serotonergic receptors in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

A single-site, double-blind, placebo-controlled, dose-ranging study of YKP10A--a putative, new antidepressant

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Cytokines, stress, and depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Serotonin brain circuits involved in major depression and suicide

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Localized decrease in serotonin transporter-immunoreactive axons in the prefrontal cortex of depressed subjects committing suicide

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Monoamine depletion in unmedicated depressed subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Psychological and behavioural effects of interferons

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Molecular detection of interferon-alpha expression in multiple sclerosis brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Indomethacin attenuates oxytocin and hypothalamic-pituitary-adrenal axis responses to systemic interleukin-1 beta

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Prediction of the depressive effects of interferon alfa therapy by the patient's initial affective state.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Treatment of cytokine-induced depression

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh-TNF-alpha, IL-1beta and IFN-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Effects of antidepressants on cytokine production and actions.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

A human interferon that crosses the species line

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Mechanisms of fever induced by recombinant human interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Neuronal plasticity and survival in mood disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Regulation of adult neurogenesis by antidepressant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

The role of cyclo-oxygenase and lipoxygenase in the interleukin-1-induced activation of the HPA axis: dependence on the route of injection

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Hippocampal changes in patients with a first episode of major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

The corticosteroid receptor hypothesis of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Interferons: potential roles in affect

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Prefrontal cortical hypometabolism during low-dose interferon alpha treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Effect of single intracerebroventricular injection of alpha-interferon on monoamine concentrations in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Repetitive transcranial magnetic stimulation increases the release of dopamine in the mesolimbic and mesostriatal system

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Dopaminergic abnormalities in amygdaloid nuclei in major depression: a postmortem study

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Acute effects of interferon beta-1a on plasma cytokine levels in patients with MS

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

The immune system, depression and the action of antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Loss of striatal vesicular monoamine transporter protein (VMAT2) in human cocaine users

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Major depression and activation of the inflammatory response system

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Enhancement of immobility in mouse forced swimming test by treatment with human interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Human interferon-alpha induces immobility in the mouse forced swimming test: involvement of the opioid system

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Human interferon-alpha increases immobility in the forced swimming test in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Involvement of central opioid systems in human interferon-alpha induced immobility in the mouse forced swimming test

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

The cellular neurobiology of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Effects of adverse experiences for brain structure and function

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Anti-inflammatory drugs and Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Interferon-alpha inhibits long-term potentiation and unmasks a long-term depression in the rat hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Human recombinant interferon alpha inhibits naloxone binding to rat brain membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Effects of interferon-alpha, interferon-gamma and cAMP on the transcriptional regulation of the serotonin transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Neurobiology of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Effect of continuous intravenous injection of interleukin-6 and pretreatment with cyclooxygenase inhibitor on brain c-fos expression in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

A study on antigenicity of recombinant human interferon alpha A (LBD-007) in mice and guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Effects of the inhibition of cyclo-oxygenase 1 or 2 or 5-lipoxygenase on the activation of the hypothalamic-pituitary-adrenal axis induced by interleukin-1beta in the male Rat

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Multiple active sites on human interferons

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Depression: a new animal model sensitive to antidepressant treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Regulation of the human serotonin transporter by interleukin-1 beta

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Acute interferon-alpha administration modulates sucrose consumption in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Antidepressant reversal of interferon-alpha-induced anhedonia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Inhibition of neural and neuroendocrine activity by alpha-interferon: neuroendocrine, electrophysiological, and biochemical studies in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Increase in serum interleukin-6, plasma ACTH and serum cortisol levels after systemic interferon-alpha administration

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Repeated interferon-alpha administration inhibits dopaminergic neural activity in the mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Distribution of alpha interferon in serum and cerebrospinal fluid after systemic administration

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Modulation of 5-HT1A receptor mediated response by fluoxetine in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

The effect of flurbiprofen and tiaprofenic acid on serum cytokine levels of patients with osteoarthrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Childhood trauma associated with smaller hippocampal volume in women with major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Cytokines, "depression due to a general medical condition," and antidepressant drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

Intrathecal synthesis of different alpha-interferons in patients with various neurological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2803%2902757-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-8993(03)02757-4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44466837&oldid=2024925619"